INDICATORS ON KIDNEY DISEASE STEM CELLS YOU SHOULD KNOW

A Canadian group analyzed clinical trials in which BM-MSCs had been applied. right after an intensive Evaluation of 36 experiments, they identified that there was no partnership between using MSCs and tumorigenic prospective, and no major Uncomfortable side effects in the therapy have been reported89. The safety and influence of MSCs therapy were a